IRIDEX, Mountain View, Calif.-based laser-based medical systems development company, has announced the recent sale of over $500,000 of its laser systems designed to treat eye conditions to the Brazilian, Russian, Chinese and Indian markets. IRIDEX CEO and President Will Moore believes these sales are due in part to a shift in the ophthalmology market from drug-based treatments towards laser-based treatments.
More Articles on Ophthalmology:
InSite Vision to Present at ARVO 2013
Glaucoma Management Lens to be Presented at ARVO 2013
3 Statistics on Cataract Surgery Procedure Times in ASCs